Curcumin Down-Regulates CD44 Marker Expresion and Inhibits the Growth of Tumorsphere in 3D Culture Condition of Gastric Cancer Cell line MKN45
Main Article Content
Abstract
Stomach cancer is the fifth most common cancer in the world. In Vietnam, the number of deaths by stomach cancer ranks third after lung cancer and liver cancer. Finding naturally occurring compounds that can effectively inhibit tumor is very important in the treatment of cancer, especially for developing countries as Vietnam. This study showed that curcumin has ability to inhibit stomach cancer evaluated on a 3D culture model. This is a model that has many advantages compared to the traditional model (2D) for screening of new drugs. Research results show that curcumin had significantly reduced the expression of CD44 stem cell marker on the gastric cancer. Curcumin inhibited the formation of tumorsphere in non-adhering culture conditions 3D. In addition, curcumin reduced the size of the tumorspheres compared to the control.
Keywords:
gastric cancer stem cell, cancer stem cell marker, curcumin, 3D culture.
References
[1] F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin 68 (2018) 394-424. https://doi.org/10.3322/caac.21492.
[2] Z. Yu, T.G. Pestell, M.P. Lisanti, R.G. Pestell, Cancer stem cells, Int J Biochem Cell Biol 44 (2012) 2144-51. https://doi.org/10.1016/j.biocel. 2012.08.022.
[3] M. Shibata, M.O. Hoque, Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer, Cancers (Basel) 11 (2019). https://doi. org/10.3390/cancers11050732.
[4] H. Hatcher, R. Planalp, J. Cho, F.M. Torti, S.V, Torti, Curcumin: from ancient medicine to current clinical trials, Cell Mol Life Sci 65 (2008) 1631-52.https://doi.org/10.1007/s00018-008-7452-4.
[5] J. Ravindran, S. Prasad, B.B. Aggarwal, Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11 (2009) 495-510.https://doi.org/10.1208/s12248-009-9128-x.
[6] S. Zhou, D. Yao, L. Guo, L. Teng, Curcumin suppresses gastric cancer by inhibiting gastrin-mediated acid secretion, FEBS Open Bio 7 (2017) 1078-84.https://doi.org/10.1002/2211-5463.12237.
[7] M. Jakubek, Z. Kejík, R. Kaplánek, R. Hromádka, V. Šandriková, D. Sýkora, et al, Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer, Biomedicine & Pharmacotherapy 118 (2019) 109278.https://doi. org/10.1016/j.biopha.2019.109278.
[8] Y. Li, T. Zhang, Targeting cancer stem cells by curcumin and clinical applications, Cancer Letters 346 (2014) 197-205.https://doi.org/10.1016/j.can let.2014.01.012.
[9] W.T. Kim, C.J. Ryu, Cancer stem cell surface markers on normal stem cells, BMB Rep 50 (2017) 285-98.https://doi.org/10.5483/bmbrep.2017. 50.6.03.
[10] P.H. Nguyen, J. Giraud, L. Chambonnier, P. Dubus, L. Wittkop, G. Belleannée, et al, Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma, Clin Cancer Res 23 (2017) 1586-97.https://doi.org/10.1158/1078-0432. CCR -15-2157.
[11] S. Misra, V.C. Hascall, R.R. Markwald, S. Ghatak, Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer, Front Immunol6(2015). https://doi.org/10.3389/fimmu. 2015.00201.
[12] S. Takaishi, T. Okumura, S. Tu, S.S.W. Wang, W. Shibata, R. Vigneshwaran, et al, Identification of gastric cancer stem cells using the cell surface marker CD44, Stem Cells 27 (2009) 1006-20.https://doi.org/10.1002/stem.30.
[13] P.H. Nguyen, Giraud J, C. Staedel, L. Chambonnier, P. Dubus, E. Chevret, et al, All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth, Oncogene 35 (2016) 5619-28.https://doi.org/10.1038/onc.2016.87.
[14] P.H. Nguyen, J. Giraud, C. Staedel, L. Chambonnier, P. Dubus, E. Chevret, et al, All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth, Oncogene 35 (2016) 5619-28.https://doi.org/10.1038/onc.2016.87.
[15] S. Takaishi, T. Okumura, S. Tu, S.S.W. Wang, Shibata W, Vigneshwaran R, et al, Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44, Stem Cells 27 (2009) 1006-20.https://doi.org/10.1002/stem.30.
[16] P.H. Nguyen, J. Giraud, L. Chambonnier, P. Dubus, L. Wittkop, G. Belleannée, et al, Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma, Clin Cancer Res 23 (2017) 1586-97.https://doi.org/10.1158/1078-0432.CCR -15-2157.
[17] W. Quarni, R. Dutta, R. Green, S. Katiri, B. Patel, S.S. Mohapatra, et al, Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells, Sci Rep 9 (2019) 15202. https://doi.org/10.1038/s41598-019-50917-3.
[18] L. Yang, P. Shi, G. Zhao, J. Xu, W. Peng, J. Zhang, et al, Targeting cancer stem cell pathways for cancer therapy, Signal Transduct Target Ther 5 (2020) 8.https://doi.org/10.1038/s41392-020-0110-5.
[19] V. Laszlo, Z. Valko, J. Ozsvar, I. Kovacs, T. Garay, M.A. Hoda, et al, The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma, J Mol Med 97 (2019) 231-42.https://doi.org/10.1007/s00109-018-1725-7.
[20] S. Courtois, R.V. Durán, J. Giraud, E. Sifré, J. Izotte, F. Mégraud, et al, Metformin targets gastric cancer stem cells, Eur J Cancer 84 (2017) 193-201.https://doi.org/10.1016/j.ejca.2017.07. 02.
[21] C.H. Lee, C.C. Yu, B.Y. Wang, W.W. Chang,Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs, Oncotarget 7 (2016) 1215-26.https://doi.org/10. 18632/oncotarget.6261.
[22] P. Shahi Thakuri, G.D. Luker, H. Tavana, Cyclical Treatment of Colorectal Tumor Spheroids Induces Resistance to MEK Inhibitors, Transl Oncol 12 (2019) 404-16. https://doi.org/ 10.1016/j.tranon.2018.11.009.
[23] S.C. Brüningk, I. Rivens, C. Box, U Oelfke, G. ter Haar, 3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments, Sci Rep 10 (2020) 1653.https:// doi.org/10.1038/s41598-020-58569-4.
[2] Z. Yu, T.G. Pestell, M.P. Lisanti, R.G. Pestell, Cancer stem cells, Int J Biochem Cell Biol 44 (2012) 2144-51. https://doi.org/10.1016/j.biocel. 2012.08.022.
[3] M. Shibata, M.O. Hoque, Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer, Cancers (Basel) 11 (2019). https://doi. org/10.3390/cancers11050732.
[4] H. Hatcher, R. Planalp, J. Cho, F.M. Torti, S.V, Torti, Curcumin: from ancient medicine to current clinical trials, Cell Mol Life Sci 65 (2008) 1631-52.https://doi.org/10.1007/s00018-008-7452-4.
[5] J. Ravindran, S. Prasad, B.B. Aggarwal, Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11 (2009) 495-510.https://doi.org/10.1208/s12248-009-9128-x.
[6] S. Zhou, D. Yao, L. Guo, L. Teng, Curcumin suppresses gastric cancer by inhibiting gastrin-mediated acid secretion, FEBS Open Bio 7 (2017) 1078-84.https://doi.org/10.1002/2211-5463.12237.
[7] M. Jakubek, Z. Kejík, R. Kaplánek, R. Hromádka, V. Šandriková, D. Sýkora, et al, Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer, Biomedicine & Pharmacotherapy 118 (2019) 109278.https://doi. org/10.1016/j.biopha.2019.109278.
[8] Y. Li, T. Zhang, Targeting cancer stem cells by curcumin and clinical applications, Cancer Letters 346 (2014) 197-205.https://doi.org/10.1016/j.can let.2014.01.012.
[9] W.T. Kim, C.J. Ryu, Cancer stem cell surface markers on normal stem cells, BMB Rep 50 (2017) 285-98.https://doi.org/10.5483/bmbrep.2017. 50.6.03.
[10] P.H. Nguyen, J. Giraud, L. Chambonnier, P. Dubus, L. Wittkop, G. Belleannée, et al, Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma, Clin Cancer Res 23 (2017) 1586-97.https://doi.org/10.1158/1078-0432. CCR -15-2157.
[11] S. Misra, V.C. Hascall, R.R. Markwald, S. Ghatak, Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer, Front Immunol6(2015). https://doi.org/10.3389/fimmu. 2015.00201.
[12] S. Takaishi, T. Okumura, S. Tu, S.S.W. Wang, W. Shibata, R. Vigneshwaran, et al, Identification of gastric cancer stem cells using the cell surface marker CD44, Stem Cells 27 (2009) 1006-20.https://doi.org/10.1002/stem.30.
[13] P.H. Nguyen, Giraud J, C. Staedel, L. Chambonnier, P. Dubus, E. Chevret, et al, All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth, Oncogene 35 (2016) 5619-28.https://doi.org/10.1038/onc.2016.87.
[14] P.H. Nguyen, J. Giraud, C. Staedel, L. Chambonnier, P. Dubus, E. Chevret, et al, All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth, Oncogene 35 (2016) 5619-28.https://doi.org/10.1038/onc.2016.87.
[15] S. Takaishi, T. Okumura, S. Tu, S.S.W. Wang, Shibata W, Vigneshwaran R, et al, Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44, Stem Cells 27 (2009) 1006-20.https://doi.org/10.1002/stem.30.
[16] P.H. Nguyen, J. Giraud, L. Chambonnier, P. Dubus, L. Wittkop, G. Belleannée, et al, Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma, Clin Cancer Res 23 (2017) 1586-97.https://doi.org/10.1158/1078-0432.CCR -15-2157.
[17] W. Quarni, R. Dutta, R. Green, S. Katiri, B. Patel, S.S. Mohapatra, et al, Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells, Sci Rep 9 (2019) 15202. https://doi.org/10.1038/s41598-019-50917-3.
[18] L. Yang, P. Shi, G. Zhao, J. Xu, W. Peng, J. Zhang, et al, Targeting cancer stem cell pathways for cancer therapy, Signal Transduct Target Ther 5 (2020) 8.https://doi.org/10.1038/s41392-020-0110-5.
[19] V. Laszlo, Z. Valko, J. Ozsvar, I. Kovacs, T. Garay, M.A. Hoda, et al, The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma, J Mol Med 97 (2019) 231-42.https://doi.org/10.1007/s00109-018-1725-7.
[20] S. Courtois, R.V. Durán, J. Giraud, E. Sifré, J. Izotte, F. Mégraud, et al, Metformin targets gastric cancer stem cells, Eur J Cancer 84 (2017) 193-201.https://doi.org/10.1016/j.ejca.2017.07. 02.
[21] C.H. Lee, C.C. Yu, B.Y. Wang, W.W. Chang,Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs, Oncotarget 7 (2016) 1215-26.https://doi.org/10. 18632/oncotarget.6261.
[22] P. Shahi Thakuri, G.D. Luker, H. Tavana, Cyclical Treatment of Colorectal Tumor Spheroids Induces Resistance to MEK Inhibitors, Transl Oncol 12 (2019) 404-16. https://doi.org/ 10.1016/j.tranon.2018.11.009.
[23] S.C. Brüningk, I. Rivens, C. Box, U Oelfke, G. ter Haar, 3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments, Sci Rep 10 (2020) 1653.https:// doi.org/10.1038/s41598-020-58569-4.